Case 2 Flashcards
what is bronchial asthma
a disease characterised by widespread narrowing of the peripheral airways varying in severity over short periods of time either spontaneously or in response to treatment
childhood asthma is:
extrinsic, atopic and mediated by antigens
adult asthma is:
intrinsic, idiosyncratic and mediated by neurological reflexes
some specific triggers of asthma are:
- excreta of house dust mites
- pollens
- exercise or emotion
- cold air
- animal fur
- respiratory tract infections
features of an asthmatic airway
- hypertrophy and hyperplasia of smooth muscle
- absence of ciliated epithelium
- thickened basal membrane
- mucus plug
what is there almost a complete loss of in airways of asthmatic patients
epithelium
first part of the role of a leucocyte:
- allergen attaches to macrophage (antigen presenting cell)
- then activates CD4+, Th2 lymphocyte
the pathway from activated lymphocyte IL4
- interleukin 4
- b lymphocyte then differentiates into a plasma cell
- secretes the IgE antibody
pathway from lymphocyte to IL5
- IL5 activates eosinophils and mast cells with IgE antibody
allergen induced release of mediators from sensitised mast cells
- the mast cell bears the IgE antibody
- there is a release of early mediators including eosinophil chemotactic factor
- released of later mediators (synthesised de novo)
allergen induced release of mediators from sensitised eosinophils
- eosinophil bearing the IgE antibody
- it releases the major basic protein
- leads to epithelial desquamation
what are the pre-formed mediators of a mast cell
- histamine
- proteases
- proteoglycans
- chemotactic factors
what are the later mediators of a mast cell derived from membrane lipids
- leukotrienes
- prostaglandins
- thromboxanes
- prostacyclin
effect of histamine on bronchial asthma
contraction of airways smooth muscle, increases vascular permeability and increased bronchial secretions
effect of chemotactic factors on bronchial asthma
- infiltration of airway wall by neutrophils and eosinophils
effects of leukotriene, C4, D4, E4 and prostaglandin D2
- contraction of airways smooth ,muscle, increased permeability and increased bronchial secretions
- major basic protein from eosinophils: epithelial desquamations
- B-cell activating factor: much later mediator
efficacy
efficacy is the tendency of the drug to activate the receptor. drugs with maximum efficacy are termed as full agonists. antagonists on the other hand have zero efficacy. when they bind, they do not active the receptor they just simply block the activity of an agonist
is efficacy released to affinity
no. affinity tells us how tightly something binds, and both agonists and antagonists have affinity
what does the Functional Gaddum Equation do
describes the effect produced by agonist D in the precedes of a competitive antagonists 1
what is a partial agonist
is a drug that cannot fully activate a receptor, even when all the receptors in a system are occupied.
how do partial agonists differ from full agonists
they have lower efficacy. not related to potency.
what is a superagonist
simply a drug who’s efficacy exceeds that of a full agonist (natural)
what is conformational selection
when a receptor visits the active site in the presence of a full agonist, the agonist binds and ‘locks’ it in the active state.
action of antagonists
they bind equally as tight to the inactive and active states. this prevents activation by agonists because of competition but the ramifications are a bit deeper.
what is a partial agonists
molecule that binds tighter to the active state than the inactive, but does not select between the two states as much as a full agonist does. the efficacy of a partial agonist depends on the ratio of inactive/active
what kind of control are smooth muscle conducting airways under
autonomic control
innervation of the diaphragm
phrenic nerve, cervical plexus (C3-C5)
Innervation of intercostal muscles
innervation of intercostal muscles
T1-T12
innervation of abdominal muscles
thoracic and lumbar
automatic respiratory rhythm generation model
- respiratory pacemaker in the medulla - will generate a respiratory rhythm in isolation, with no input
- pacemaker -> ‘pattern generation’ -> output to pump muscles and upper airways
what is the pacemaker region
pre-botzinger
sensory inputs to the respiratory centres
- peripheral chemoreceptors
- carotid bodies and aortic arch
- arterial stimulus
other sensory inputs to the respiratory centre
central chemoreceptors
- located on the surface of the medulla
sensory input from lungs, airways and chest wall
- nose - trigeminal (V)
- pharynx - glossopharyngeal (IX) and vagus (X)
- lungs - vagus (X)
- chest wall - spinal nerves
stretch receptors
predominantly in the trachea and main bronchi
- repsond to lung inflation
irritant receptors
- naso-pharync, larynx, bronchi and trachea
- mechanical, chemical irritant stimuli and inflammatory mediators
C-fibres
- receptors ‘free’ nerve endings
- larynx, trachea, bronchi , lungs (J-receptors)
- chemical irritant stimuli, inflammatory mediators and lung oedema (J-receptors)
normal range of values of blood gases while breathing air
Hb - 23.3-17.7 g/dl
pH - 7.37 - 7.45 units
PCO2 - 4.7-6.4 kPa
PO2 - over 10.7 kPa
calculated base excess values:
-2 to +2 mmol.l-1
acidosis
Respiratory: increased PCO2
Metabolic: decreased HCO3-
alkalosis
respiratory: deceased PCO2
metabolic: increased HC03-
Type 1 respiratory failure
- hypoxaemic failure
- low PaO2
- normal or low PaC02
- disturbance of the relationship of ventilation to perfusion
- mismatch of regional perfusion and ventilation
type II respiratory failure
- ventilatory failure
- low Pa02 and raised PaC02
- alveolar ventilation is reduced
- if type I and II are present together this is known as mixed respiratory failure
which genes are associated with asthma
- ADAM33 gene is associated with airway hyper-responsiveness and airway remodelling
- PHF11 gene is associated with increased IgE production